Matinas Biopharma (6LJ0.F) Q2 2025 Earnings

15AprConfirmed
Q3 2024
Q4 2024
Q2 2025
-1.14
-0.99
-0.84
-0.69

Details

Expected EPS
-0.690534
Actual EPS
N/A
Surprise EPS
0.69
Surprise Percent
+100%

Description

Matinas Biopharma (6LJ0.F) will report earnings of for Q2 2025 on April 15, 2025.

0 Comments

Share your thoughts